Nitric oxide-independent vasodilator rescues heme-oxidized soluble guanylate cyclase from proteasomal degradation.
نویسندگان
چکیده
Nitric oxide (NO) is an essential vasodilator. In vascular diseases, oxidative stress attenuates NO signaling by both chemical scavenging of free NO and oxidation and downregulation of its major intracellular receptor, the alphabeta heterodimeric heme-containing soluble guanylate cyclase (sGC). Oxidation can also induce loss of the heme of sGC, as well as the responsiveness of sGC to NO. sGC activators such as BAY 58-2667 bind to oxidized/heme-free sGC and reactivate the enzyme to exert disease-specific vasodilation. Here, we show that oxidation-induced downregulation of sGC protein extends to isolated blood vessels. Mechanistically, degradation was triggered through sGC ubiquitination and proteasomal degradation. The heme-binding site ligand BAY 58-2667 prevented sGC ubiquitination and stabilized both alpha and beta subunits. Collectively, our data establish oxidation-ubiquitination of sGC as a modulator of NO/cGMP signaling and point to a new mechanism of action for sGC activating vasodilators by stabilizing their receptor, oxidized/heme-free sGC.
منابع مشابه
Nitric oxide-independent vasodilator rescues heme-oxidized soluble guanylate cyclase from proteosomal degradation
Open Access Poster presentation Nitric oxide-independent vasodilator rescues heme-oxidized soluble guanylate cyclase from proteosomal degradation Sabine Meurer1,2, Sylke Pioch2, Tatjana Pabst2, Nils Opitz1,2,3, Peter M Schmidt1,4, Tobias Beckhaus5, Kristina Wagner2, Simone Matt2, Kristina Gegenbauer1,6, Sandra Geschka7,8, Michael Karas5, JohannesPeter Stasch7,9, Harald HHW Schmidt1 and Werner M...
متن کاملRole of the sGC activator ataciguat sodium (HMR1766) in cardiovascular disease
Background Soluble guanylate cyclase (sGC), the key transducer of nitric oxide (NO) signaling, exists in two redox forms: the NO sensitive ferrous heme iron (Fe(II)) form and a NO insensitive oxidized form containing the ferric heme iron (Fe(III)). Ataciguat sodium (further named ataciguat) predominantly stimulates the oxidized form of sGC. To further define the therapeutic potential of atacigu...
متن کاملAntiplatelet effects of aspirin are not affected by the soluble guanylate cyclase activator cinaciguat (BAY 58-2667)
Introduction Cinaciguat (BAY 58-2667) is an nitric oxide (NO)-independent and heme-independent soluble guanylate cyclase (sGC) activator. Cinaciguat preferentially activates sGC in its oxidized or heme-free state, when the enzyme is insensitive to its endogenous ligand NO and exogenous nitrovasodilators [1]. Endothelium-derived NO is one of the mechanisms by which platelet aggregation and throm...
متن کاملTargeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels.
ROS are a risk factor of several cardiovascular disorders and interfere with NO/soluble guanylyl cyclase/cyclic GMP (NO/sGC/cGMP) signaling through scavenging of NO and formation of the strong oxidant peroxynitrite. Increased oxidative stress affects the heme-containing NO receptor sGC by both decreasing its expression levels and impairing NO-induced activation, making vasodilator therapy with ...
متن کاملSoluble guanylate cyclase modulators in heart failure.
This review summarizes the role of soluble guanylate cyclase (sGC)-cyclic guanosine 3', 5'-monophosphate pathways in heart failure and several new drugs that modify guanylate cyclase. The sGC activators and stimulators as modulators of sGC are promising drugs in the therapy for decompensated heart failure and pulmonary hypertension. Cinaciguat is a nitric oxide (NO)-independent direct activator...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Circulation research
دوره 105 1 شماره
صفحات -
تاریخ انتشار 2009